MedPath

A Study To Compare Efficacy Of Dexmedetomidine And Midazolam For Sedation And Reduction Of Dose Of Propofol In Minor Gynaecological Day Care Surgeries

Recruiting
Conditions
Gynaecological patients
Registration Number
CTRI/2018/04/013106
Lead Sponsor
NA
Brief Summary

Ambulatory surgery is  continually evolving speciality in majority of surgical procedures. Dexmedetomidine and midazolam are newer adjuvants for sedation and reducing the dose of anaesthetic agents. Aim of this study was to compare the sedative and propofol sparing effect of dexmedetomidine and midazolam in minor gynaecological day care fitness score were studied as primary outcomes. Hemodynamic parameters and side effects were evaluated as secondary outcomes. ***Results****:* Sedation score was statistically highly significant between group A and B (p<0.001). Between group A and C, it was statistically significant (p <0.05), however score was non significant  between groups B and C (p  >0.05). During recovery at 120 minutes after surgery, score 5 was achieved equally by all  three groups which was found to be statistically  insignificant (p > 0.05). Mean dose of additional propofol used, was less in group A (14±9.25) than B (25±5.40) and C (53±10.96). On intergroup comparison between all three groups, it was found to be statistically highly significant (p<0.001). Comparison of BIS values between group A and C and group B and C were highly significant p<0.001. However, it was statistically significant between group A and B (p <0.05). Aldrete scoring and Street Fitness Scores were highly significant between groups A and B, B and C and also between group A and C (p<0.001). No significant hemodynamic derangements and side effects were noted in any of three groups. ***Conclusion*** *:* dexmedetomidine had good sedation and better recovery characteristics than midazolam. BIS monitoring was helpful in maintaining surgeries under BIS monitored general anaesthesia. ***Material and methods****:*  a prospective randomized placebo controlled study was conducted on 150 physical status ASA I and II gynaecological patients between 18 to 50 years were allocated into 3 groups of fifty each. Group A received IV dexmedetomidine 0.1 µ.kg-1, group B received IV midazolam 0.04 mg.kg-1 and group C received normal saline 10 minutes before induction. Observers assessment for activity and sedation score (OAA/S), additional dose of propofol required, recovery characteristics using aldrete and street depth of anesthesia thereby reducing requirement of other anesthetic agents.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
150
Inclusion Criteria

Patients undergoing elective minor gynaecological day care surgeries of <1 hour duration like tubectomy, dilatation & curettage, suction & evacuation, endometrial biopsies, cervical biopsies, polypectomies, cervical stitching etc.

Exclusion Criteria
  • 1 Patients on alpha adrenergic receptor blocker 2 Patient with known hypersensitivity to study drug 3 Compromised cardiac patients, renal or hepatic disease patients 4 Patients with some psychiatric history.
  • 5 Patients with neurological disease with motor and sensory deficit.
  • •Patient allergic to egg •Pregnant patients.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
additional dose of propofol required, sedation scores and recovery characteristics.two hours
Secondary Outcome Measures
NameTimeMethod
Hemodynamic parameters and side effects of study drugtwo hours

Trial Locations

Locations (1)

SGRDIMSR

🇮🇳

Amritsar, PUNJAB, India

SGRDIMSR
🇮🇳Amritsar, PUNJAB, India
Dr Ruchi Gupta
Principal investigator
9464091324
drruchisgrd@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.